近期论文
查看导师新发文章
(温馨提示:请注意重名现象,建议点开原文通过作者单位确认)
Nishtala, P., Gnjidic, D., Jamieson, H., Hanger, C., Kaluarachchi, C., Hilmer, S. (2016). 'Real-world' haemorrhagic rates for warfarin and dabigatran using population-level data in New Zealand. International Journal of Cardiology, 203, 746-752. [More Information]
Held, F., Blyth, F., Gnjidic, D., Hirani, V., Naganathan, V., Waite, L., Seibel, M., Rollo, J., Handelsman, D., Cumming, R., Le Couteur, D. (2016). Association Rules Analysis of Comorbidity and Multimorbidity: The Concord Health and Aging in Men Project. Journals of Gerontology. Series A: Biological Sciences and Medical Sciences, 71(5), 625-631. [More Information]
Nishtala, P., Gnjidic, D., Chyou, T., Hilmer, S. (2016). Discontinuation of statins in a population of older New Zealanders with limited life expectancy. Internal Medicine Journal, 46(4), 493-496. [More Information]
Kouladjian-O'Donnell, L., Chen, T., Gnjidic, D., Hilmer, S. (2016). Education and Assessment of Pharmacists on the Use of the Drug Burden Index in Older Adults Using a Continuing Professional Development Education Method. American Journal of Pharmaceutical Education, 80(4), 1-7. [More Information]
Jamsen, K., Bell, J., Hilmer, S., Kirkpatrick, N., Ilomaki, J., Le Couteur, D., Blyth, F., Handelsman, D., Waite, L., Naganathan, V., Cumming, R., Gnjidic, D. (2016). Effects of Changes in Number of Medications and Drug Burden Index Exposure on Transitions between Frailty States and Death: The Concord Health and Ageing in Men Project Cohort Study. Journal of the American Geriatrics Society, 64(1), 89-95. [More Information]
Kouladjian-O'Donnell, L., Gnjidic, D., Reeve, E., Chen, T., Hilmer, S. (2016). Health Care Practitioners' Perspectives on Deprescribing Anticholinergic and Sedative Medications in Older Adults. The Annals of Pharmacotherapy, 50(8), 625-636. [More Information]
Thai, M., Reeve, E., Hilmer, S., Qi, K., Pearson, S., Gnjidic, D. (2016). Prevalence of statin-drug interactions in older people: A systematic review. European Journal of Clinical Pharmacology, 72(5), 513-521. [More Information]
Gnjidic, D., Fastbom, J., Fratiglioni, L., Rizzuto, D., Angleman, S., Johnell, K. (2016). Statin Therapy and Dementia in Older Adults: Role of Disease Severity and Multimorbidity. Journal of the American Geriatrics Society, 64(1), 223-224. [More Information]
Reeve, E., Gnjidic, D., Long, J., Hilmer, S. (2015). A systematic review of the emerging definition of 'deprescribing' with network analysis: Implications for future research and clinical practice. British Journal of Clinical Pharmacology, 80(6), 1254-1268. [More Information]
Parkinson, L., Magin, P., Thomson, A., Byles, J., Caughey, G., Etherton-Beer, C., Gnjidic, D., Hilmer, S., Thomas King, T., McCowan, C., et al (2015). Anticholinergic burden in older women: not seeing the wood for the trees? Medical Journal of Australia, 202(2), 91-95. [More Information]
Gnjidic, D., Elshaug, A. (2015). De-adoption and its 43 related terms: harmonizing low-value care terminology. BMC Medicine, 13(1), 1-3. [More Information]
Gnjidic, D., Bennett, A., Le Couteur, D., Blyth, F., Cumming, R., Waite, L., Handelsman, D., Naganathan, V., Matthews, S., Hilmer, S. (2015). Ischemic heart disease, prescription of optimal medical therapy and geriatric syndromes in community-dwelling older men: A population-based study. International Journal of Cardiology, 192, 49-55. [More Information]
Gnjidic, D., Pearson, S., Hilmer, S., Basilakis, J., Schaffer, A., Blyth, F., Banks, E. (2015). Manual versus automated coding of free-text self-reported medication data in the 45 and Up Study: a validation study. Public Health Research and Practice, 25(2), 1-9. [More Information]
Pont, L., Nielen, J., McLachlan, A., Gnjidic, D., Chan, L., Cumming, R., Taxis, K. (2015). Measuring anticholinergic drug exposure in older community-dwelling Australian men: A comparison of four different measures. British Journal of Clinical Pharmacology, 80(5), 1169-1175. [More Information]
Qi, K., Reeve, E., Hilmer, S., Pearson, S., Matthews, S., Gnjidic, D. (2015). Older peoples' attitudes regarding polypharmacy, statin use and willingness to have statins deprescribed in Australia. International Journal of Clinical Pharmacy, 37(5), 949-957. [More Information]
Thai, M., Hilmer, S., Pearson, S., Reeve, E., Gnjidic, D. (2015). Prevalence of Potential and Clinically Relevant Statin–Drug Interactions in Frail and Robust Older Inpatients. Drugs and Aging, 32(10), 849-856. [More Information]
Scott, I., Hilmer, S., Reeve, E., Potter, K., Le Couteur, D., Rigby, D., Gnjidic, D., Del Mar, C., Roughead, E., Page, A., Jansen, J., et al (2015). Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Internal Medicine, 175(5), 827-834. [More Information]
Gnjidic, D., Naganathan, V., Freedman, S., Beer, C., McLachlan, A., Hilmer, S., Figtree, G. (2015). Statin therapy and cognition in older people: What is the evidence? Current Clinical Pharmacology, 10(3), 185-193.
Gnjidic, D., Wilson, N., March, L., Cumming, R., Cameron, I., Hilmer, S. (2015). Statin utilisation patterns in older Australians living in residential care: 1-year prevalence study. Internal Medicine Journal, 45(1), 106-109. [More Information]
Reeve, E., Gnjidic, D., Hilmer, S. (2015). The role of the OncPal deprescribing guideline in end-of-life care. Supportive Care in Cancer, 23(4), 899. [More Information]